fitrianingsih, fitrianingsih and sauriasari, rani and saptaningsih, agusdini banun (2017) COST-EFFECTIVENESS ANALYSIS ON THE USE OF PARENTERAL NUTRITION WITH D10-CA GLUCONATE AND D5 1/4NS IN NORMAL-WEIGHT NEONATES WITH RESPIRATORY DISTRESS SYNDROME. International Journal of Applied Pharmaceutics, 9 (1). pp. 62-66. ISSN 0975-7058
Text
COST EFFECTIVENESS-2017.pdf Download (936kB) |
Abstract
weight neonatal patients with Respiratory Distress Syndrome (RDS) in Kambang General Hospital, Jambi, Indonesia. Methods: The research was conducted from September 2014 to June 2015. The study participants were divided into two groups; D10-CaGluconate was administered to 40 patients and D5 1/4NS to 43 patients. Effectiveness was assessed based on the changes in the physical examination results, average weight gain (28.48 and 23.49 g/day), blood glucose levels (26.73 and 26.42 mg/dL), respiratory rate (−12.35 breaths/minute and −7.77 breaths/minute), pulse frequency (−10.98 and −8.07 ±), and body temperature (0.013°C and 0.012°C) of the patients in the D10-CaGluconate and D5 1/4NS groups, respectively. Results: The average direct medical costs of using D10-CaGluconate and D5 1/4NS were 458,290 IDR and 408,347 IDR, respectively. The average cost- effectiveness ratio value of total direct medical costs for D10-CaGluconate preparation was 35,207,467 IDR while that for D5 1/4NS was 33,958,602 IDR. The direct medical cost of the incremental cost-effectiveness ratio mean value of the D5 1/4NS preparation that compared to the D10-CaGluconate preparation was 10,017,210 IDR. Conclusions: The parenteral nutrition preparation of D10-CaGluconate is more cost-effective than that of D5 1/4NS.
Type: | Article |
---|---|
Subjects: | R Medicine > RM Therapeutics. Pharmacology |
Divisions: | Fakultas Kedokteran dan Ilmu Kesehatan > Farmasi |
Depositing User: | FITRIANINGSIH |
Date Deposited: | 22 Mar 2021 11:54 |
Last Modified: | 22 Mar 2021 11:54 |
URI: | https://repository.unja.ac.id/id/eprint/18885 |
Actions (login required)
View Item |